← FDA Drug Approvals (Drugs@FDA)

BUMETANIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APPCO · Approved 2024-09-18

Drug application

FDA Application #

ANDA212931

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUMETANIDE

Generic name

BUMETANIDE

Active ingredients

BUMETANIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

APPCO

Manufacturer

Exelan Pharmaceuticals, Inc.

First approval

2024-09-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown